Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dropless Pars Plana Vitrectomy Study
NCT05331664Phase 4Completed
- Sponsor
- Massachusetts Eye and Ear
- Start
- Jul 2022
- Primary completion
- Jul 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in rhegmatogenous retinal detachment (RRD), sponsored by Massachusetts Eye and Ear. Started Jul 2022; status: completed.
02
Drugs
triamcinolone
03
Conditions
rhegmatogenous retinal detachment (RRD)
Beyond the preview
Go deeper on NCT05331664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05331664.